Click on faculty member’s name for credentials and biography.

Katie E. Barber, PharmD
Associate Professor
Department of Pharmacy Practice
University of Mississippi School of Pharmacy
Jackson, MS

Dr. Barber completed a Postgraduate Year Two (PGY-2) Residency in Infectious Diseases at the Detroit Medical Center in 2012 and Infectious Diseases Pharmacokinetic/Pharmacodynamic Fellowship at Wayne State University in 2014. She currently practices at the University of Mississippi Medical Center on the Infectious Diseases Consultation Team.

Kee Kee Buckley

Patient Advocate
Hampton, NJ

Kee Kee is a New Jersey-based writer, producer, and director of independent films and documentaries. She is a founding partner of Ad Hoc Media Partners, a production company that has several music and travel docuseries in various stages of production. She is also the Co-founder of the River Town Film Festival in Clinton, NJ.

As an active member of the Peggy Lillis Foundation’s Advocate’s council, she has co-written an eating guide for C. difficile patients and is working to ensure that the needs of C. difficile sufferers are heard. Kee Kee is a patient spokesperson for Ferring Pharmaceuticals and has spoken on panels at various conferences about C. difficile.

Kimberly C. Claeys, PharmD

Associate Professor – Infectious Diseases
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Center for Innovation in Diagnosis
University of Maryland School of Medicine
Baltimore, MD

Dr. Claeys serves as an Antimicrobial Stewardship Pharmacist at University of Maryland Medical Center. She completed her PharmD at Wayne State University in Detroit, MI, and a Pharmacy Practice Residency at Associate the University of Illinois at Chicago College of Pharmacy and University of Illinois at Chicago.

After residency, she completed a two-year Infectious Diseases and Health Outcomes Fellowship at the Anti-Infective Laboratory at Wayne State University. She is now completing a PhD in Epidemiology with a focus on Diagnostic Stewardship of Healthcare Associated Infections with the University of Maryland School of Medicine. Her research interests include Infectious diseases epidemiology, translation research involving rapid molecular diagnostic testing, and antimicrobial and diagnostic stewardship, including the intersection of these disciplines.

Amy L. Dzierba, PharmD, FCCM, FCCP, BCCCP

Clinical Pharmacy Manager, Adult Critical Care
New York-Presbyterian Hospital
Columbia University Irving Medical Center
New York, NY

Dr. Dzierba completed her undergraduate work and Doctor of Pharmacy degree at Midwestern University School of Pharmacy in Glendale, AZ.  She completed her PGY1 pharmacy residency at Grady Health System in Atlanta, GA, followed by a Post-Graduate Year 2 pharmacy residency in critical care at the University of Washington / Harborview Medical Center in Seattle, WA.

She is a panel member of the NIH COVID-19 guidelines and author on the SCC COVID-19 guidelines.

Dr. Dzierba is an active member of the Society of Critical Care Medicine and American College of Clinical Pharmacy.

Greg A. Eschenauer, PharmD

Clinical Associate Professor of Pharmacy
University of Michigan College of Pharmacy
Ann Arbor, MI

Dr. Eschenauer is a Clinical Associate Professor in the Department of Clinical Pharmacy at the University of Michigan College of Pharmacy and clinical pharmacy specialist in infectious diseases at Michigan Medicine.

Dr. Eschenauer received his Doctor of Pharmacy from Butler University and completed his pharmacy practice and infectious diseases specialty residencies at the University of Michigan. Since completing his residency, he has served as an infectious diseases clinical pharmacist at New York Presbyterian Hospital and the University of Pittsburgh Medical Center prior to joining the University of Michigan.

Valeria Fabre, MD

Assistant Professor of Medicine
Division of Infectious Diseases
Johns Hopkins University
Associate Medical Director
Antimicrobial Stewardship Program
The Johns Hopkins Hospital
Baltimore, MD

Dr. Fabre graduated with honors from the University of Buenos Aires School of Medicine. She completed her internal medicine residency at Brown and her ID fellowship at Johns Hopkins University. She is the associate medical director of the Antimicrobial Stewardship Program and an Associate Hospital Epidemiologist at The Johns Hopkins Hospital.

She was the recipient of the SHEA Research Scholar Award for her proposal on blood culture stewardship. Her research interests include diagnostic stewardship and new strategies to promote optimal antibiotic use in acute care hospitals, both domestically and internationally.

Dr. Fabre is currently the principal investigator of three CDC funded projects to study blood culture utilization in the United States, and to assess antimicrobial stewardship and infection prevention and control programs in Central and South America. She is co-investigator in other federally funded projects on antimicrobial stewardship both in the US and abroad. She serves on both the IDSA and SHEA diagnostic committees and is a member of the SHEA External Affairs Committee and the SHEA Diversity and Inclusion committees.

Kevin W. Garey, PharmD, MS

Professor and Chair
University of Houston College of Pharmacy
Houston, TX

Dr. Garey is Chair of the Department of Pharmacy Practice and Translational Research.  He is an Adjunct Professor at the University of Texas School of Public Health and a Clinical Specialist and Researcher at Baylor St. Luke’s Medical Center, Houston, TX.

He received a Bachelor of Science in Pharmacy degree from Dalhousie University in Halifax, Nova Scotia, Canada, a Doctor of Pharmacy from SUNY Buffalo in Buffalo, NY, and a Masters of Science in Biometry from the University of Texas School of Public Health.  Postdoctoral training includes a pharmacy practice residency at Bassett Healthcare, Cooperstown, NY, and infectious disease specialty residency and fellowship training at the University of Illinois at Chicago, Chicago, IL.

Dr. Garey is a Fellow of the Infectious Diseases Society of American (IDSA) and a member of the IDSA-Society of Healthcare Epidemiology of America (SHEA) practice guidelines for C. difficile infection.  He is an active member of the Society of Infectious Diseases Pharmacists (SIDP) and a Fellow of the American Society of Health-system Pharmacists (FASHP) and American College of Clinical Pharmacy (FCCP). He has been awarded several national awards including the ASHP Best Practice Award in Health-system Pharmacy Administration (2010), the ASHP Drug Therapy Research Award (2007), and the SIDP Impact Paper in Infectious Diseases Pharmacotherapy Research Award (2007, 2012).  He received the University of Houston PLS leadership award in 2013.

Dr. Garey’s research is supported by the National Institutes of Health, the Centers for Disease Control and Prevention, and the biotechnology industry.  He has published over 220 manuscripts centered on clinical and translational research in healthcare associated infections including healthcare-related infections, candidemia, and Clostridium difficile infection.

Matthew B. Goetz, MD

Chief, Infectious Diseases
VA Greater Los Angeles Healthcare System
Professor of Clinical Medicine
David Geffen School of Medicine at UCLA
Los Angeles, CA

Dr. Goetz also serves as Associate Program Director of the UCLA Multicampus Infectious Diseases Fellowship Program.

He earned his medical degree from Tufts University School of Medicine in Boston, MA. He completed his residency in internal medicine at Hennepin County Medical Center in Minneapolis, MN, followed by a research and clinical fellowship in infectious diseases at the University of Wisconsin.

Dr. Goetz serves on the Medical Advisory Panel to the VA Pharmacy Benefits Management Group and is a member of the VA Antimicrobial Stewardship Taskforce, Infectious Diseases Field Advisory Committee, and the National HIV Technical Advisory Group.  He has previously served on the FDA Anti-Microbial Drug Advisory Committee.

He has been an investigator on projects sponsored by the VA, NIH and the CDC that range from interventional studies to improve antimicrobial stewardship programs to assessments of long-term outcomes.  He is a member of the editorial advisory board of Clinical Infectious Diseases and JAIDS: Journal of Acquired Immune Deficiency Syndromes.  He has published over 200 peer-reviewed articles.

David R. Ha, PharmD, BCIDP

Infectious Diseases and Antimicrobial Stewardship Pharmacist
Stanford Health Care
Stanford, CA

Dr. Ha is manager of antimicrobial stewardship with the Stanford Antimicrobial Safety and Sustainability Program at Stanford Health Care and lecturer in infectious diseases at the Stanford University School of Medicine in Palo Alto, CA.

He also serves as PGY2 infectious diseases pharmacy residency program coordinator at Stanford Health Care. His professional and research interests include antimicrobial stewardship, infectious diseases pharmacotherapy, and public health.

Emily L. Heil, PharmD, MS, BCIDP, AAHIVP

Associate Professor – Infectious Diseases
Department of Pharmacy Practice and Science
University of Maryland School of Pharmacy
Clinical Associate Professor
Department of Medicine, Division of Infectious Diseases
University of Maryland School of Medicine
Baltimore, MD

Dr. Heil completed her undergraduate and PharmD at the University of North Carolina in Chapel Hill and subsequently completed her pharmacy practice and infectious diseases pharmacy residency training at the University of North Carolina Hospitals. She completed her Master of Science in Clinical Research and Epidemiology at the University of Maryland School of Medicine.

Dr. Heil serves as the Pharmacy Director of the Antimicrobial Stewardship Program at the University of Maryland Medical Center. She also provides clinical pharmacy services to the infectious diseases consults services, the inpatient HIV medicine team and the outpatient infectious diseases clinic. During the COVID-19 pandemic she served as the infectious diseases representative on the system medication  management team and led the development and maintenance of the system COVID-19 treatment guidelines.

Bruce M. Jones, PharmD, FIDSA, BCPS

Infectious Diseases Clinical Pharmacy Specialist
St. Joseph’s/Candler Health System, Inc.
Clinical Adjunct Associate Professor
University of Georgia College of Pharmacy
Savannah, GA

Dr. Jones practices in the Savannah City-Wide Antimicrobial Management Program.  He also serves as an Adjunct Clinical Associate Professor for the University of Georgia College of Pharmacy, and a Clinical Preceptor for Mercer University, University of Georgia, University of South Carolina, and South University Schools of Pharmacy.

He received his Doctor of Pharmacy degree from East Tennessee State University Gatton College of Pharmacy in Johnson City, TN. He completed a Postgraduate Year One (PGY1) Pharmacy Practice Residency at St. Joseph’s/Candler Health System.

Dr. Jones is a member of IDSA, GSHP, ACCP, SIDP, and the Southeastern Research Group Endeavor (SERGE-45). Dr. Jones currently serves on the BPS Pharmacotherapy Specialty Council and is board certified in Pharmacotherapy (BCPS).

Colleen R. Kelly, MD, FACG

Associate Professor of Medicine
Warren Alpert Medical School of Brown University
Providence, RI

The focus of Dr. Kelly’s research and clinical practice is Clostridium difficile infection (CDI) and fecal microbiota transplantation (FMT).  She was the principal investigator (PI) for a first placebo-controlled trial of FMT for treatment of recurrent CDI and one of the first investigators to sponsor an investigational new drug (IND) application for FMT with the Food and Drug Administration.

She has since served on several working groups focusing on regulatory issues related to FMT.  Dr. Kelly is currently site PI for an industry funded trial of live microbiota for treatment of recurrent CDI, and investigator-Initiated clinical trials assessing conventional FMT for CDI treatment. Dr. Kelly is interested in the long-term effects around manipulation of gut microbiota and serves as one of the PIs for an NIH-funded FMT National Registry which will answer important questions around the safety of FMT. She has collaborated on several studies investigating the impact of FMT on patients with Inflammatory Bowel Disease, Nonalcoholic Fatty Liver Disease and Alopecia Areata.

In addition to coauthoring current FMT guidelines and participating in drafting the European Consensus Conference on Fecal Microbiota Transplant in Clinical Practice, Dr. Kelly serves as the primary author for the recently published American College of Gastroenterology (ACG) 2019 C. difficile treatment guidelines.  She is a Fellow in the ACG, and a Fellow and past member of the scientific advisory board for Gut Microbiome Research and Education for the American Gastroenterological Association.

Meshell Maxam, PharmD, BCIDP

HIV/Infectious Diseases Clinical Pharmacy Specialist
Kaiser Permanente Georgia
Atlanta, GA

Dr. Maxam received her Bachelor of Science in Biology at the University of Georgia (Go Dawgs!) and earned her Doctor of Pharmacy degree from the Medical University of South Carolina. Dr. Maxam completed a PGY-1 Pharmacy Residency at Wake Forest Baptist Health, and a PGY-2 Infectious Diseases Pharmacy Residency at Grady Health System.

Her professional interests include HIV and antimicrobial stewardship.

Larissa S. May, MD, MSPH, MSHS

Professor of Emergency Medicine
Director of ED and Outpatient Antibiotic Stewardship
Medical Director, Learning Health System Hub
UC Davis Health
Antibiotic Stewardship Lead, VA Northern California Healthcare System
Sacramento, CA

Dr. May is a national expert in antibiotic stewardship in the emergency department (ED).  She received her MD (2002), her MSPH in Public Health Microbiology and Emerging Infectious Diseases (2008), and her MSHS in Clinical and Translational Research (2013) from The George Washington University.

She completed her residency training at the George Washington University in 2006. Dr. May’s research interests center on the application of rapid molecular diagnostic assays, behavioral economics and clinical guidelines to improve antibiotic stewardship and other patient safety and quality improvement efforts in the ED and urgent care setting.

Dr. May served as an investigator on multiple federally-funded and industry-funded trials evaluating antimicrobial stewardship strategies in the ED, and has published over 90 peer-reviewed articles in her field.  She also served on numerous committees and task forces focused on antibiotic stewardship, emergency preparedness, and infectious diseases surveillance for the Centers for Disease Control and Prevention, the National Institutes of Health, and professional organizations including the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America.

Erin K. McCreary, PharmD, BCPS, BCIDP

Clinical Assistant Professor
University of Pittsburgh School of Medicine
Division of Infectious Diseases.
Pittsburgh, PA

Dr. McCreary is also Director of Stewardship Innovation for UPMC and ID Connect. She received her PharmD from the Auburn University Harrison School of Pharmacy and completed her PGY1 Pharmacy and PGY2 Infectious Diseases residencies at the University of Wisconsin Health.

Dr. McCreary co-chairs the UPMC COVID-19 Therapeutics Committee and serves as a co-investigator for the REMAP-CAP trial, a global, adaptive, clinical trial evaluating multiple therapies for COVID-19. She is also the lead pharmacist and co-investigator for OPTIMISE-C19, the UPMC monoclonal antibody therapy for COVID-19 trial. She has published numerous peer-reviewed manuscripts in the areas of antimicrobial stewardship and infectious diseases. She also serves on the Society of Infectious Diseases Pharmacists Executive Board and a host of Breakpoints—The SIDP Podcast.

Her practice and research interests include infectious diseases and antimicrobial stewardship in immunocompromised hosts, Gram-negative resistance, and antimicrobial pharmacokinetic/pharmacodynamic optimization. She is also passionate about professional leadership, mentorship, and preceptorship.

Nicholas Mercuro, PharmD, BCIDP

Clinical Pharmacist
Infectious Diseases
Maine Medical Center
Portland, ME

Dr. Mercuro graduated from the University of Rhode Island in 2015. He completed a PGY1 residency at Henry Ford Hospital and a PGY2 Infectious Diseases residency at Maine Medical Center. He completed a fellowship in antimicrobial stewardship outcomes research at Wayne State University and returned to his hometown in Boston, MA to work at Beth Israel Deaconess Medical Center.

Currently, Dr. Mercuro practices antimicrobial stewardship and infectious diseases pharmacotherapy at Maine Medical Center in Portland, ME, with interests in antimicrobial safety, resistance, and teaching.

Kaede Ota Sullivan, MD, MSc, FRCPC, FAAP, D(ABMM)

Professor and Director of Faculty Affairs
Department of Pathology & Laboratory Medicine
Lewis Katz School of Medicine at Temple University
Associate Director of Clinical Microbiology & Immunology
Temple University Health System
Philadelphia, PA

Dr. Ota Sullivan is a board-certified infectious diseases specialist and medical microbiologist. She is  Associate Director of the Microbiology, Virology & Immunology Laboratories with the Temple University Health System.

She received her Doctor of Medicine at McMaster University in Canada and holds a Master’s degree in Epidemiology and Health Care Research from the University of Toronto. Dr. Ota  Sullivan has served on a number of national committees including the SHEA Diagnostic Stewardship Task Force, the HICPAC NHSN Surveillance Workgroup, and the College of American Pathologists’ Microbiology Committee.

Her research focuses on optimization of microbiology laboratory procedures that impact infection prevention and antimicrobial stewardship initiatives.

Payal K. Patel, MD, MPH

Assistant Professor
Division of Infectious Diseases
University of Michigan Health System
Ann Arbor, MI

Payal Patel is an infectious diseases physician at the University of Michigan and medical director of antimicrobial stewardship at the VA Ann Arbor Healthcare System.

She is also a consultant for the CDC’s international infection prevention team with specific interests in strengthening antimicrobial stewardship internationally.  Dr. Patel mentors medical students, internal medicine residents, infectious diseases fellows and pharmacists in the field of antimicrobial stewardship, and has appeared as a medical correspondent on BBC World, NBC, NPR, and PBS Newshour.

Jason M. Pogue, PharmD, FCCP, BCIDP

Clinical Professor
Department of Clinical Pharmacy
University of Michigan College of Pharmacy
Ann Arbor, MI

Dr. Pogue is an Infectious Diseases Clinical Pharmacist at Michigan Medicine. Prior to this position he spent just over a decade at the Detroit Medical Center (DMC) as an Infectious Diseases Clinical Pharmacist at Sinai-Grace Hospital and as the co-chair of the Antimicrobial Stewardship Committee at the DMC.

Dr. Pogue received a bachelor’s degree in chemistry from Gannon University, before obtaining his Doctor of Pharmacy degree from the University of Pittsburgh. He completed a PGY-1 pharmacy residency at the University of Pittsburgh Medical Center followed by an infectious diseases PGY-2 residency at the University of Michigan Health Systems. His research interests focus on epidemiology and management of multi-drug resistant Gram-negative organisms and antimicrobial stewardship.

Dr. Pogue is a recognized leader in Gram-negative resistance and antimicrobial stewardship as evidenced by his significant contribution of over 125 peer-reviewed articles, over 125 abstracts, multiple book chapters, and presentations at numerous national and international conferences. He served as clinical pharmacy lead for multiple NIH funded studies addressing optimal use of polymyxins for XDR Gram-negative pathogens.

Dr. Pogue is a past president of the Society of Infectious Diseases Pharmacists and currently serves as Chair of the Executive Committee of The United States Committee on Antimicrobial Susceptibility Testing (USCAST).

David van Duin, MD, PhD, FIDSA, FAST

Professor of Medicine
Director, Immunocompromised Host Infectious Diseases Program
Division of Infectious Diseases
University of North Carolina
Chapel Hill, NC

Dr. van Duin is the founding Director of the Immunocompromised Host ID service.  His main research interests are multi-drug resistant Gram-negative bacteria, and infections in immunocompromised patients.

He is interested in the community origins of highly resistant bacteria. He is the PI for the MDRO Network of the Antibacterial Resistance Leadership Group.

John A. Bosso, PharmD

Professor Emeritus
Colleges of Pharmacy and Medicine
Medical University of South Carolina
Charleston, SC

Dr. Bosso earned his Bachelor of Science in Pharmacy and Doctor of Pharmacy degrees from the State University of New York at Buffalo. He served on the faculties of the University of Utah Colleges of Pharmacy and Medicine, the University of Houston College of Pharmacy, and Baylor College of Medicine in Houston, TX. His last position was as Professor, Department of Clinical Pharmacy & Outcomes Sciences, and the Department of Medicine in the Division of Infectious Diseases, Colleges of Pharmacy and Medicine, Medical University of South Carolina in Charleston, SC, where he maintains Professor Emeritus status in both colleges. Clinically, Dr. Bosso served as a Clinical Specialist in Infectious Diseases and as Program Director of the Infectious Diseases Residency at MUSC.

He was board certified in Pharmacotherapy with added qualifications in Infectious Diseases. His research focused on anti-infective pharmacokinetics, pharmacodynamics, and efficacy in both pediatric and adult patients as well as the nature of the antibiotic use – resistance development relationship. The latter represents a focus area for research and teaching in recent years.

He has published results of his work (over 140 original publications in the peer reviewed literature) in professional and scientific journals, and written chapters for textbooks including Pharmacotherapy. A Pathophysiologic Approach, The Pharmacotherapy Self-Assessment Program, and The Textbook of Pediatric Infectious Diseases.

In recent years Dr. Bosso has been active in the creation and delivery of education and training programs in the area of antimicrobial stewardship. He was a Scientific Editor for the journal Pharmacotherapy and various pharmacy journals, and served as a reviewer for numerous others.

Dr. Bosso has been active in a number of professional organizations. He was a founding member and is a past-president of the Society of Infectious Diseases Pharmacists, and is also a past president of the American College of Clinical Pharmacy. He is a Fellow of the American College of Clinical Pharmacy and the Infectious Diseases Society of America. He helped found Making a Difference in Infectious Diseases and served as President and member of the Board of Directors until September of 2021.